Patient_ID	irRECIST	Study_site	Gender	Age	Disease_Status	Overall_Survival	Vital_Status	Previous_MAPKi	Anatomical_Location	BRAF	NRAS	NF1	Treatment	Biopsy_Time	WES	RNAseq
Pt1	Progressive_Disease	UCLA	F	66	M1b	607	Dead	N	L post. Thigh, inf., SC	-	Q61L		Pembrolizumab	pre-treatment	1	1
Pt2	Partial_Response	UCLA	M	55	M1c	927	Alive	N	Lung	-	-	Frame_Shift_Ins H31fs, Splice_Site	Pembrolizumab	pre-treatment	1	1
Pt3	Partial_Response	UCLA	M	58	M1c	691	Dead	N	Bowel	V600K	-	E572K	Pembrolizumab	pre-treatment	1	0
Pt4	Partial_Response	UCLA	M	62	M1c	948	Alive	Y	Adrenal	L331F	-	S2597*	Pembrolizumab	pre-treatment	1	1
Pt5	Partial_Response	UCLA	M	61	M1c	439	Alive	N	L Chestwall, SC	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt6	Partial_Response	UCLA	M	51	M1c	882	Alive	Y	L forearm, SC	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt7	Progressive_Disease	UCLA	F	55	M1c	662	Dead	N	Crown/scalp, SC		-	-	Pembrolizumab	pre-treatment	1	1
Pt8	Complete_Response	UCLA	M	69	M1a	NA	Alive	N	R leg, SC	V600R	-	-	Pembrolizumab	pre-treatment	1	1
Pt9	Complete_Response	UCLA	M	68	M0	1054	Alive	N	L forearm, SC	V600K	-	-	Pembrolizumab	pre-treatment	1	1
Pt10	Progressive_Disease	UCLA	M	60	M1a	387	Alive	Y	Neck, SC		-	-	Pembrolizumab	pre-treatment	1	1
Pt11	Progressive_Disease	UCLA	M	37	M1c	467	Dead	N	L face, C	V600E	-	-	Pembrolizumab	on-treatment	1	0
Pt12	Progressive_Disease	UCLA	M	59	M1c	327	Dead	N	L lower abdomen, SC	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt13	Complete_Response	UCLA	F	53	M1c	917	Alive	N	Lower back, SC		-	-	Pembrolizumab	pre-treatment	1	1
Pt14	Progressive_Disease	UCLA	F	27	M1c	54	Alive	N	R neck, SC	V600E	-	R2349C	Pembrolizumab	pre-treatment	1	1
Pt15	Partial_Response	UCLA	M	70	M1b	980	Dead	Y	R clavicle, LN	-	G13D	Q1255*	Pembrolizumab	pre-treatment	1	1
Pt16	Progressive_Disease	UCLA	M	19	M1b	186	Dead	Y	Lung	V600E	-	-	Pembrolizumab	on-treatment	1	1
Pt17	Progressive_Disease	UCLA	M	67	M1a	953	Dead	N	Scalp, SC	V600K	-	-	Pembrolizumab	on-treatment	1	0
Pt18	Partial_Response	UCLA	M	64	M1c	1081	Alive	N	R Axilla, LN	V600E	-	-	Pembrolizumab	pre-treatment	1	0
Pt19	Partial_Response	UCLA	M	45	M1c	1060	Alive	N	Chest, SC	-	Q61K	-	Pembrolizumab	pre-treatment	1	1
Pt20	Progressive_Disease	UCLA	F	63	M1c	337	Dead	N	L clavicle	-	Q61R	K615K Splice Site	Pembrolizumab	pre-treatment	1	1
Pt21	Partial_Response	UCLA	M	60	M1b	945	Dead	N	Lung	L597P	-	-	Pembrolizumab	pre-treatment	1*	0
Pt22	Progressive_Disease	UCLA	M	55	M1c	182	Dead	N	Left Flank, SC	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt23	Progressive_Disease	UCLA	M	63	M1c	103	Dead	Y	Left Leg, SC	V600K	-	-	Pembrolizumab	pre-treatment	1	1
Pt24	Partial_Response	UCLA	M	70	M1c	974	Dead	N	L Inguinal, LN	-	Q61K	-	Pembrolizumab	pre-treatment	1*	0
Pt25	Progressive_Disease	UCLA	M	74	M1c	262	Dead	Y	L Outer Inguinal	-	-	-	Pembrolizumab	pre-treatment	1	1
Pt26	Complete_Response	UCLA	M	71	M1c	1336	Alive	Y	L Inguinal	-	-	R440*	Pembrolizumab	on-treatment	1	0
Pt27	Complete_Response	UCLA	M	83	M1c	548	Alive	N	R upper arm	-	T50I	-	Pembrolizumab	pre-treatment	1	1
									R upper back	-	T50I	-	Pembrolizumab	pre-treatment	1^	1
Pt28	Partial_Response	UCLA	M	82	M1c	439	Dead	N	Scalp, SC	-	-	R1653C	Pembrolizumab	pre-treatment	1	1
Pt29	Progressive_Disease	UCLA	M	84	M1c	269	Dead	Y	Lung	-	-	-	Pembrolizumab	pre-treatment	1	1
Pt30	Progressive_Disease	VIC	F	80	M1c	100	Dead	N	Retrocecal mass	-	Q61L	-	Pembrolizumab	pre-treatment	1	0
Pt31	Progressive_Disease	VIC	M	47	M1c	704	Alive	N	Sigmoid colon	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt32	Progressive_Disease	VIC	M	47	M1c	171	Dead	Y	Abdominal wall	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt33	Complete_Response	VIC	F	80	M1a	2177	Alive	N	Groin, SC	-	Q61R	-	Nivolumab	pre-treatment	1	0
Pt34	Complete_Response	VIC	M	42	M1c	418	Alive	Y	Abdominal wall	-	Q61K	-	Pembrolizumab	pre-treatment	1	0
Pt35	Partial_Response	VIC	F	65	M1c	427	Alive	Y	Flank	V600E	-	-	Pembrolizumab	pre-treatment	1	1
Pt36	Progressive_Disease	VIC	F	61	M1a	837	Dead	N	Axillary LN	-	-	-	Nivolumab	pre-treatment	1	0
Pt37	Partial_Response	VIC	F	70	M1c	364	Alive	Y	Small bowel	K483T, D594N	-	-	Pembrolizumab	pre-treatment	1	1
Pt38	Partial_Response	VIC	F	57	M1c	448	Alive	Y	Cervical, LN	-	-	-	Pembrolizumab	pre-treatment	1	1

